News from NYU Langone Health
New Heart Stents For Infants Mean Kids Could Avoid Series Of Surgeries. (NBC News)
NBC News (10/17) Michael Argilla, MD, clinical associate professor, Department of Pediatrics, and director of the pediatric catheterization laboratory at NYU Langone Health, described the FDA-approved Minima stent for infants and young children as a “game-changer,” as it allows for minimally invasive adjustments to accommodate growth, potentially reducing the need for multiple open heart surgeries in children with congenital heart defects such as coarctation and stenosis.
Overwhelming Majority Of Young Americans Worry About Climate Crisis. (The Guardian (UK))
The Guardian (UK) (10/17) Research published in The Lancet Planetary Health reveals that a significant majority of young Americans, across political lines, express climate anxiety, with more than half indicating environmental concerns influence decisions on residence and childbearing; Eric Lewandowski, PhD, clinical associate professor in the Department of Child and Adolescent Psychiatry at NYU Grossman School of Medicine, observed that over 75% of respondents in every state reported climate anxiety, and more than 70% of young people desire intergenerational dialogue on climate issues, while the study involved researchers from NYU Grossman School of Medicine, Stanford University, and others, and connected mental health impacts to climate-related events such as Hurricanes Helene and Milton.
In Patchogue, Hospital Achieves Provisional Trauma II Status. (Long Island (NY) Business News)
The Long Island (NY) Business News (10/17) Long Island Community Hospital has been designated a provisional Level II trauma center by the New York State Department of Health as it prepares for its merger with NYU Langone Health, enabling it to expand acute care services and treat all adult trauma patients; Jerry A. Rubano, MD, assistant professor in the Department of Surgery at NYU Grossman Long Island School of Medicine and regional director of trauma for NYU Langone Hospital—Long Island, emphasized this achievement, stating, “Achieving the designation as a Level II trauma center is a testament to our unwavering commitment to expanding our services and providing the highest-quality care for the most severely injured patients in the community.”
The Doctor Will See You, And Stop Judging You, Now. (Scientific American)
Scientific American (10/17) In a recent discussion, Rachel Feltman and Cristina M. Gonzalez, MD, professor in the Departments of Medicine, and Population at NYU Grossman School of Medicine, explored the impact of unconscious biases in healthcare settings, examining how these biases, though often unintentional, can influence patient treatment and potentially affect health outcomes.
The Scientific American (10/17) interview is also presented as a video.
Everything You Should Know About Breast Cancer Signs And Treatments. (Allure)
Allure (10/17) Breast cancer, affecting a significant portion of the American population, presents a 13% lifetime risk for those who have undergone estrogenic puberty, with diagnoses increasingly occurring in individuals under 45; Marleen I. Meyers, MD, clinical professor in the Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center, and director of the Perlmutter Cancer Center Survivorship Program, notes that most breast cancer cases are identified through imaging techniques like mammograms or ultrasounds, particularly in those receiving regular screenings, while Elizabeth Comen, MD, associate professor, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center, advises that “the best prevention is screening, since they may not have any symptoms.”
NYU Study Finds Its 3-Year Med School Is Just As Good! (STAT)
Paywalled* STAT (10/17)* A study published in Academic Medicine by researchers from NYU Grossman School of Medicine compared the training performances of 136 graduates from its three-year accelerated program to 681 graduates of the traditional four-year program, finding similar outcomes in both school and internships, although the study’s scope was limited to NYU students.
Also reporting is Endocrinology Advisor (10/17).
Novadip Reports Promising Interim Results From First-In-Human Proof-Of-Concept Trial Of New Game Changer In Bone Field. (Drug Development & Delivery)
Drug Development & Delivery (10/17) Novadip Biosciences has announced positive interim results from its NVDX3-CLN01 clinical trial of NVDX3, an allogeneic bone grafting material derived from mesenchymal stem cells, in treating distal radius fractures; Philipp Leucht, MD, PhD, the Raj-Sobti-Menon Associate Professor of Orthopedic Surgery in the Department of Orthopedic Surgery, associate professor in the Department of Cell Biology, and vide chair of research for the Department of Orthopedic Surgery at NYU Grossman School of Medicine, remarked, “These interim results suggest that NVDX3 may have the potential to address this unmet need,” particularly for patients with co-morbidities like advanced age, diabetes, and smoking.
Also reporting is PharmiWeb (10/17).
Vagus Nerve Stimulation Enhances Perceptual Learning In Mice. (Technology Networks)
Technology Networks (10/17) Researchers from NYU Langone Health have demonstrated that vagus nerve stimulation (VNS) enhances perceptual learning in mice by improving neuroplasticity in the auditory cortex and activating the cholinergic basal forebrain, according to a study published in Nature Neuroscience; lead author Kathleen Martin, a graduate student at the neuroscience institute at NYU Grossman School of Medicine, stated, “Our findings suggest that activating the vagus nerve during training can push past the limits of what animals, and perhaps even humans, can learn to perceive,” while senior author Robert C. Froemke, PhD, the Skirball Professor Genetics in the Department of Neuroscience and Physiology and professor in the Department of Otolayngology-Head and Neck Surgery at NYU Grossman School of Medicine, added, “These results highlight the potential of vagus nerve stimulation to speed up hearing improvements from cochlear implants.”
Common Breast Cancer Treatments May Accelerate Aging, Study Finds. (Verywell Health)
Verywell Health (10/17) A UCLA study in the Journal of the National Cancer Institute reveals that breast cancer treatments like chemotherapy, radiation, and surgery may accelerate aging by increasing markers of cellular aging such as DNA damage and inflammation in survivors, with Ruth Oratz, MD, clinical professor in the Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center, acknowledging that while treatments can hasten aging or menopause, physicians can offer remedies for side effects, emphasizing the importance of continuing effective treatments while managing side effects like weight gain with new drugs, and highlighting the role of lifestyle factors in offering protection against biological aging.
NYU Langone Health Physician Discusses Study Linking Hormonal IUDs, Slight Increase In Breast Cancer Risk. (NBC News Now-2)
NBC News Now-2 (10/17) A study published in the Journal of the American Medical Association indicates a slight increase in breast cancer risk for women using hormonal IUDs long-term, comparable to the risk linked with oral contraceptives; Natalie E. Azar, MD, a clinical associate professor in the Department of Medicine, Division of Rheumatology at NYU Grossman School of Medicine, explains that while the risk appears significant, it represents a small increase from one to 1.4 per 200 women, advising women with genetic or familial risk factors to consider non-hormonal alternatives and consult healthcare providers, noting study limitations such as potential increased healthcare system engagement by IUD users potentially skewing results.
NYU Langone Health Physician Discusses Study Linking COVID-19 Infection And Diabetes In Children And Listeria Recall. (WNYW-NY (FOX)-3)
WNYW-NY (FOX)-3 (10/17) Purvi S. Parikh, MD, clinical assistant professor in the Departments of Pediatrics, and Medicine, Division of Infectious Disease, Allergy and Immunology, at NYU Grossman School of Medicine, discussed a new study involving over 600,000 children aged 10 to 19, which found a 66% average risk of developing type 1 diabetes within one, three, and six months after a COVID-19 infection, potentially linked to long COVID syndromes and autoimmune responses, while also addressing a major listeria outbreak resulting in the recall of 12 million pounds of meat and poultry from stores like Trader Joe’s, Costco, and Walmart, and advising high-risk groups to ensure food is well-cooked and seek medical attention if symptoms arise.
